EC-5026

N/A

Report date: 2026/02/28 20:00:37
NME

Base Information

Drug NameEC-5026
Drug Alias Namet-TUCBEC-5026BPN-19186
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionEpoxide hydratase inhibitors
TargetsEpoxide hydratase
Therapy Area/IndicationsPainNeuralgiaDiabetic Neuropathies +[8] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesNew Zealand
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesThe University Of California Davis
China Registration ClassN/A

Develop Information

Active CompaniesEicOsis LLCThe University Of California DavisEicosis Human Health Inc
Inactive CompaniesN/A
Active IndicationsPainNeuralgiaDiabetic Neuropathies +[8] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A